CAMBRIDGE, Mass.--(BUSINESS WIRE)--Civetta Therapeutics, LLC announced a $53 million Series A financing to advance select programs and a proprietary platform focused on beta-propeller proteins.
The first production Bugatti Bolide, chassis number 001, is set to cross the auction block at Gooding & Company’s Pebble Beach Auctions on August 15-16, with estimates suggesting it could fetch ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback